Treatment of HER2-Expressing Breast Cancer and Ovarian Cancer Cells With Alpha Particle-Emitting 227Th-Trastuzumab

Helèn Heyerdahl(Nordic Nanovector (Norway)), Jostein Dahle(Oslo University Hospital), Cecilie Krogh(Oslo University Hospital), Jørgen Borrebæk(Bayer (Norway)), Åsmund Larsen(Oslo University Hospital)
International Journal of Radiation Oncology*Biology*Physics
January 1, 2011
Cited by 42


Related Papers